AUS
NZ
UK
CA
USA
IND
Healthcare
Willow Biosciences Engages in Innovative Project with Leading API Manufacturer
September 19, 2024 02:32 PM EDT| By Team Kalkine MediaIn the,Healthcare sector,, Willow Biosciences Inc. has announced a second collaboration with a prominent Active Pharmaceutical Ingredient (API) manufacturer. This partnership aims to develop a more sustainable and cost-effective manufacturing route f...
Roquefort’s STAT-6 siRNA Effective in Trials, Eyes Licensing
September 19, 2024 01:44 PM EDT| By Team Kalkine MediaRoquefort Therapeutics has recently highlighted significant advancements in its STAT-6 siRNA program, providing an update on promising results obtained from a validated in vitro model of immunological disease. This novel therapeutic approach utilizes...
Breakthrough Device For Pediatric Sleep Apnea Approved By FDA
September 18, 2024 10:38 AM EDT| By Team Kalkine MediaVivos Therapeutics has announced the receipt of US Food and Drug Administration (FDA) approval for its oral medical device designed to treat moderate to severe obstructive sleep apnea (OSA) in children aged 6 to 17. This innovative device offers a no...
Immunic Unveils Lead Asset For Multiple Sclerosis At ECTRIMS
September 18, 2024 09:25 AM EDT| By Team Kalkine MediaImmunic Inc has presented significant data on its primary asset, vidofludimus calcium, at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). This congress, held from September 18 to 20 in Copenhage...
MustGrow Partners With Agriculture Canada For Mustard Seed Breakthrough
September 17, 2024 01:03 PM EDT| By Team Kalkine MediaMustGrow Biologics Corp. (,TSXV:MGRO,) has received funding from Agriculture and Agri-Food Canada (AAFC) to explore the potential of mustard-derived ingredients for applications in human and animal health. This support, granted through the AgriScienc...
Voyageur Pharmaceuticals Appoints New Chief Science Officer
September 17, 2024 12:43 PM EDT| By Team Kalkine MediaVoyageur Pharmaceuticals Ltd (,TSXV:VM,) has announced a significant addition to its executive team with the appointment of Dr. Iryna Saranchova as the new Chief Science Officer. Dr. Saranchova joins Voyageur from MYND Life Sciences, where she held t...
Lisata Therapeutics Begins Second Cohort Treatment In Bile Duct Cancer Trial
September 17, 2024 12:26 PM EDT| By Team Kalkine MediaLisata Therapeutics Inc,(NASDAQ:LSTA),. has initiated treatment in the second-line cholangiocarcinoma (CCA) cohort of its BOLSTER trial. Cholangiocarcinoma, often referred to as bile duct cancer, is a rare and aggressive cancer with a five-year survi...
Savaria Chief Legal Officer & Corporate Secretary Sylvain Aubry Reduces Holding By 81%
September 16, 2024 03:12 PM EDT| By Team Kalkine MediaSavaria Corporation (,TSX:SIS,), a prominent player in the healthcare sector, has recently seen notable insider transactions. Sylvain Aubry, the Chief Legal Officer & Corporate Secretary, recently sold shares worth CA$415,000 at an average price of C...
Andlauer Healthcare Group Inc.: Financials Remain Robust Despite Recent Stock Weakness
September 13, 2024 02:13 PM EDT| By Team Kalkine MediaRecent performance data for Andlauer Healthcare Group (,TSX:AND,) has shown a 4.8% decline in its stock value over the past week. This decline may raise concerns for stakeholders, but a closer inspection of the company’s financial metrics could provi...
Immunic CEO Highlights New York MS R&D Day and Vidofludimus Calcium in MS Studies
September 13, 2024 07:33 AM EDT| By Team Kalkine MediaImmunic Inc,(NASDAQ:IMUX),recently provided an update on its progress in developing vidofludimus calcium, a promising treatment for multiple sclerosis (MS). CEO Daniel Vitt shared insights into the company's advancements during an interview with Proa...
Limited Concerns About Cardiol Therapeutics' Cash Burn Rate
September 12, 2024 12:50 PM EDT| By Team Kalkine MediaOwning shares in companies that are not yet profitable can be lucrative, as evidenced by Cardiol Therapeutics,(TSX:CRDL),, which has seen a remarkable 136% increase in its share price over the past year. This impressive gain highlights the potential...
Risks Remain Elevated as Nova Leap Health Corp. Shares Drop 27%
September 12, 2024 06:47 AM EDT| By Team Kalkine MediaNova Leap Health Corp.,(TSXV:NLH),has recently faced a substantial drop in its share price, with a decline of 27% over the past thirty days. Despite this, the stock has shown resilience over a longer timeframe, rising by 21% over the last year. This...
Improved Revenues Needed for iAnthus Capital Holdings, Inc. Stock's Recent Surge to Be Justified
September 10, 2024 02:47 PM EDT| By Team Kalkine MediaiAnthus Capital Holdings, Inc.,(OTH:ITHUF),has recently demonstrated impressive performance, with its share price showing a notable 33% gain over the past month. This uptick marks a significant recovery from previous declines. Despite this positive s...
Cardiol Therapeutics to Present Results from Phase 2 Recurrent Pericarditis Study
September 10, 2024 01:53 PM EDT| By Team Kalkine MediaCardiol Therapeutics,(TSX:CRDL),has completed its Phase 2 MAvERIC-Pilot study evaluating the effects of its novel therapy, CardiolRx, on patients with recurrent pericarditis. The company plans to present the comprehensive results at the American Hear...
Is WELL Health Technologies a High-Risk Opportunity?
September 09, 2024 02:16 PM EDT| By Team Kalkine MediaHoward Marks eloquently highlighted the primary concern in financial management: “The possibility of permanent loss is the risk I worry about... and every practical individual I know worries about.” When evaluating a company’s financial stability, as...
Risks and Challenges for Lifeist Wellness in the Healthcare Sector
September 06, 2024 03:03 PM EDT| By Team Kalkine MediaThe,healthcare sector,has recently seen significant fluctuations, impacting various companies including Lifeist Wellness Inc. Lifeist Wellness, listed on the TSX Venture Exchange, has garnered attention due to its performance and market conditions. H...
Voyageur Pharmaceuticals Advances Diagnostic Products Toward FDA Approval
September 05, 2024 03:43 PM EDT| By Team Kalkine MediaIn the,Healthcare sector,, Voyageur Pharmaceuticals has reached a significant milestone with the completion of its innovative diagnostic product formulations. This development marks a crucial step as the company prepares to seek approval from the U.S...
Evaluating Risk Factors for TerrAscend Inc.
September 03, 2024 10:30 AM EDT| By Team Kalkine MediaTerrAscend Inc. operates within the,Healthcare sector,, focusing on cannabis and related products. An evaluation of the company's financial stability and operational performance provides insight into its risk profile.,Company Performance and Risk Ass...
Assessing the Financial Health of Microbix Biosystems
August 22, 2024 12:00 AM EDT| By Team Kalkine MediaMicrobix Biosystems Inc., operating within the,Healthcare sector,, has recently drawn attention due to its earnings performance. Stakeholders are urged to take a closer look at the company’s financial results to better understand its current position...
A Look at Dividends in a Leading Senior Care Stock
August 21, 2024 12:00 AM EDT| By Team Kalkine MediaThe,healthcare sector,, particularly senior housing and care services, continues to be a significant focus in Canada due to the country's aging population. This environment supports companies like Extendicare , which operates within this sector and o...
